Director/PDMR Shareholding

In brief · summary, not quotable

Brendan Buckley, a Non-Executive Director of hVIVO plc, has sold 2,017,000 ordinary shares at 8.65p per share, totaling £174,470.50. Following this transaction, Mr. Buckley now holds 2,000,270 ordinary shares and has indicated he will not seek re-election at the upcoming Annual General Meeting. This sale represents a significant disposal of shares by a director and is considered inside information.

Full announcement

Select text to share a quote on X · sign in to keep highlights & notes in your HVO notes

London, UK - 24 April 2026, hVIVO plc (AIM: HVO), a purpose-built, full-service international clinical development partner and the world leader in human challenge trials, has been notified that Brendan Buckley, Non-Executive Director, has sold 2,017,000 ordinary shares of £0.001 each in the Company ("Ordinary Shares") at a price of 8.65p per Ordinary Share.

Following this transaction, Brendan Buckley, who has informed the Company of his intention not to stand for re-election at the upcoming AGM, now holds 2,000,270 Ordinary Shares in the Company.

Peel Hunt LLP (Joint Broker)		+44 (0)20 7418 8900
James Steel, Dr Christopher Golden
Davy (Joint Broker)		+353 (0) 1 679 6363
Anthony Farrell, Niall Gilchrist
a.	Name of PDMR	Brendan Buckley
	2	Reason for notification
a.	Position/Status	Non-Executive Director
b.	Initial notification/ Amendment	Initial notification
a.	Name	hVIVO plc
b.	LEI	213800VT5KBM7JLIV118
a.	Description of the financial instrument, type of instrument Identification Code	Ordinary shares of £0.001 each ISIN GB00B9275X97
b.	Nature of the transaction	Sale of Ordinary Shares
c.	Price(s) and volume(s)	No. of Shares Price 2,017,000 8.65p
d.	Aggregated information - Aggregated Volume - Price	2,017,000 8.65p
f.	Place of the transaction	London Stock Exchange, AIM Market (XLON)

Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.